Polar Asset Management Partners’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Polar Asset Management Partners’s Portfolio RVPHW Stock Details RVPHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-300,907	Closed	-$197K	–	1114
2020 Q4	$197K	Sell	300,907 -25,000	-8%	-$13.7K	﹤0.01%	735
2020 Q3	$166K	Hold	325,907	–	–	﹤0.01%	555
2020 Q2	$153K	Sell	325,907 -25,000	-7%	-$5.86K	﹤0.01%	455
2020 Q1	$32K	Sell	350,907 -19,893	-5%	-$2.98K	﹤0.01%	409
2019 Q4	$93K	Buy	370,800 +330,800	+827%	+$75.9K	﹤0.01%	391
2019 Q3	$8K	Hold	40,000	–	–	﹤0.01%	413
2019 Q2	$8K	Hold	40,000	–	–	﹤0.01%	378
2019 Q1	$6K	Hold	40,000	–	–	﹤0.01%	345
2018 Q4	$13K	Buy	+40,000	New	+$12.8K	﹤0.01%	345

Other funds holding RVPHW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Polar Asset Management Partners's RVPHW Position: Q1 2021 in Review

Polar Asset Management Partners sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q1 2021, closing a stake of 300,907 shares — an estimated $197K sold.

Polar Asset Management Partners first reported a position in RVPHW in Q4 2018 and held it in 9 quarters. The position peaked at $197K in Q4 2020. 12 funds tracked by Wall St. Rank hold RVPHW as of Q1 2021.

Polar Asset Management Partners reported no remaining Reviva Pharmaceuticals Warrants position as of Q1 2021 after selling out during the quarter.
Polar Asset Management Partners sold 300,907 Reviva Pharmaceuticals Warrants shares in Q1 2021, an estimated $197K.
Polar Asset Management Partners first reported a position in Reviva Pharmaceuticals Warrants in Q4 2018 and held it in 9 quarters.
Polar Asset Management Partners's Reviva Pharmaceuticals Warrants position peaked at $197K in Q4 2020.
12 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q1 2021.

Based on Polar Asset Management Partners's 13F filing for Q1 2021, filed 17 May 2021.